Search
News
Zevia Q2 2026 earnings: Pricing supports sales as GAAP loss widens
Zevia’s Q2 2026 net sales rose 1.1% to $45.0 million as pricing offset a 3.7% volume decline. Gross margin edged up 20 basis points to 48.9%, but the GAAP net loss widened to $2.9 million and diluted loss per share to $0.04, largely because equity-based compensation increased. Adjusted EBITDA improved to $0.5 million. Zevia ended June with $28.5 million in cash, no debt, and maintained full-year guidance for $170 million to $175 million in sales and a $2 million to $4 million adjusted EBITDA loss.
TradingKey
Wed, Aug 5
Bumble Q2 2026 Earnings: Paying-User Decline Drives a 15% Revenue Drop
Bumble Inc. (NASDAQ: BMBL) reported Q2 2026 revenue of $210.5 million, down 15.2% year over year, and a diluted loss of $0.84 per share versus $2.45 a year earlier. Total paying users fell 16.4% to 3.2 million, while total ARPPU increased 1.2% to $21.96. Adjusted EBITDA declined to $72.9 million and its margin narrowed to 34.6%. A smaller impairment charge reduced the GAAP net loss to $127.9 million, while third-quarter guidance points to roughly stable sequential revenue at the midpoint but lower adjusted EBITDA.
TradingKey
Wed, Aug 5
Exelixis Q2 2026 earnings: Cabozantinib growth lifts revenue and EPS
Exelixis reported Q2 2026 revenue of $628.7 million, up 10.6% year over year, as U.S. cabozantinib net product revenue reached $573.0 million on higher sales volume. GAAP diluted EPS increased to $0.82 from $0.65, while non-GAAP diluted EPS rose to $0.91. The company lowered its full-year total revenue and net product revenue ranges, reduced planned R&D spending, and said the guidance excludes any potential zanzalintinib revenue. Investors now face a key December 3, 2026 FDA action date for zanzalintinib in previously treated metastatic colorectal cancer.
TradingKey
Wed, Aug 5
A10 Networks Q2 2026 Earnings: Revenue Rose 15.5% as GAAP Operating Margin Narrowed
A10 Networks’ Q2 2026 earnings showed revenue of $80.1 million, up 15.5% year over year, while GAAP diluted EPS declined to $0.12 from $0.14. Product revenue rose about 25%, but faster operating-expense growth compressed GAAP operating margin to 11.3%. Adjusted EBITDA increased to $24.4 million, or 30.5% of revenue, while six-month operating cash flow fell to $31.3 million. Management raised its full-year revenue growth outlook to 12%-14% and EPS growth outlook to 14%-16%.
TradingKey
Wed, Aug 5
Dutch Bros Q2 2026 Earnings: Revenue Climbs 32.5% as Guidance Rises
Dutch Bros (NYSE: BROS) reported Q2 2026 revenue of $550.9 million, up 32.5% year over year, while diluted EPS rose to $0.28 from $0.20. Company-operated same-shop sales increased 8.3%, supported by 4.9% ticket growth and 3.4% transaction growth, and 48 new shops opened. Adjusted EBITDA advanced 27.8% to $113.7 million, though its margin narrowed to 20.6%. The company raised 2026 revenue, systemwide same-shop sales and adjusted EBITDA guidance while maintaining plans for at least 185 system openings.
TradingKey
Wed, Aug 5
Aeva Q2 2026 earnings: Gross profit turns positive but core losses persist
Aeva's Q2 2026 revenue rose about 11% to $6.1 million, while GAAP loss per share narrowed to $1.23 from $3.49. Gross profit swung to $2.2 million from a $2.7 million loss as professional-services revenue expanded, but non-GAAP operating loss widened to $26.0 million and operating expenses increased. Aeva ended June with $302.9 million of available liquidity, including $177.9 million of cash and securities, while outlining new optical-connectivity, commercial-vehicle ADAS, and industrial-sensing milestones and an upcoming CFO transition.
TradingKey
Wed, Aug 5
ParkOhio Q2 2026 earnings: Record revenue supports margin expansion
ParkOhio’s Q2 2026 revenue increased 10% year over year to a record $440.1 million, while diluted EPS from continuing operations rose to $0.87 from $0.67. Gross margin expanded 90 basis points to 17.9%, as growth across all three segments and operational initiatives improved profitability. Engineered Products benefited from aftermarket demand and a larger equipment backlog, while quarterly operating cash flow turned positive. ParkOhio raised its 2026 sales and adjusted EPS outlook, with SSP losses, debt levels and second-half cash conversion remaining central items to monitor.
TradingKey
Wed, Aug 5
Klaviyo Q2 FY2026 earnings: 26% revenue growth supports a higher outlook
Klaviyo’s fiscal Q2 2026 revenue rose 26% year over year to $370.6 million, while its GAAP net loss narrowed to $8.8 million and diluted loss per share improved to $0.03. Operating cash flow reached $93.9 million and free cash flow was $82.9 million, even as GAAP gross margin declined to 73% from about 76%. Enterprise, international and multi-product adoption supported growth, and Klaviyo raised fiscal 2026 revenue guidance to $1.526 billion-$1.534 billion, representing 24% growth.
TradingKey
Wed, Aug 5
U-Haul Fiscal Q1 2027 Earnings: Revenue Grew but Net Income Fell
U-Haul Holding Company’s fiscal Q1 2027 revenue rose approximately 3.2% to $1.682 billion, while net earnings available to common shareholders declined to $122.9 million from $142.3 million. Diluted EPS fell to $0.58 for UHAL and $0.63 for UHAL.B, and Moving and Storage adjusted EBITDA slipped to $536.7 million. Self-moving rental and self-storage revenue increased, but lower storage occupancy, higher operating expenses and increased interest expense pressured profitability despite improved results from retired rental equipment disposals. The quarter ended June 30, 2026.
TradingKey
Wed, Aug 5
Vanda Q2 2026 Earnings: Fanapt Growth Could Not Prevent a Wider Loss
Vanda Pharmaceuticals’ Q2 2026 revenue fell 4% to $50.5 million, while GAAP diluted loss per share widened to $1.04 from $0.46. Fanapt sales increased 23% to $36.0 million, but HETLIOZ sales dropped 66% to $5.6 million, with about $7.0 million of shipped orders deferred to Q3 recognition. Net loss reached $62.5 million as launch and pipeline spending lifted operating expenses. Cash and marketable securities ended June at $170.0 million, and Vanda reiterated full-year revenue guidance of $240 million to $290 million.
TradingKey
Wed, Aug 5
Axon Q2 2026 Earnings: Revenue Rises 35% as Operating Cash Flow Turns Positive
Axon’s Q2 2026 earnings showed revenue of $904.4 million, up 35.3% year over year, and adjusted EBITDA of $242.0 million at a 26.8% margin. Diluted EPS fell to $0.36 from $0.44 because the prior-year quarter included a large tax benefit, even as operating income improved to $46.8 million. Software & Services and Connected Devices both grew about 35%, operating cash flow turned positive, and Axon raised its full-year revenue growth outlook to 32%-34% while maintaining its 25.5% adjusted EBITDA margin target.
TradingKey
Wed, Aug 5
GRAIL Q2 2026 earnings: Galleri growth contrasts with a wider operating loss
GRAIL’s Q2 2026 revenue rose 26% year over year to $44.7 million, while diluted net loss per share narrowed to $2.56 from $3.18. Galleri volume exceeded 61,000 tests, up 35%, and Galleri revenue increased 24% to $42.6 million. However, the operating loss widened to $173.8 million and adjusted EBITDA loss increased 15% to $90.3 million as sales, marketing and administrative costs rose. GRAIL ended June with $861.6 million in cash, cash equivalents and short-term securities and expects an FDA advisory committee review in the fall.
TradingKey
Wed, Aug 5
Envista Q2 2026 Earnings: Margin Expansion Supports Higher Guidance
Envista’s Q2 2026 revenue rose 7.1% to $730.5 million, while GAAP diluted EPS increased to $0.33 from $0.16. Adjusted EBITDA grew 28% to $107.7 million and margin expanded 230 basis points to 14.7%, supported by growth in both reporting segments and operating execution. Q2 free cash flow reached $105.1 million. Following the first-half performance, Envista raised full-year guidance for core sales growth, adjusted EBITDA growth, and adjusted diluted EPS while maintaining approximately 100% free cash flow conversion.
TradingKey
Wed, Aug 5
Caris Q2 2026 earnings: Molecular profiling drives 45% revenue growth
Caris Life Sciences’ Q2 2026 revenue rose 45% to $263.7 million as molecular profiling services grew 55% and clinical cases increased approximately 18%. Gross margin expanded 500 basis points to 68%, while the company reduced its GAAP net loss to $0.6 million and generated $55.7 million of adjusted EBITDA. Operating cash flow reached $28.5 million, although higher capital investment limited free cash flow to $6.4 million. Caris also raised full-year 2026 revenue guidance to $1.03 billion-$1.04 billion, implying 27%-28% growth.
TradingKey
Wed, Aug 5
SenesTech Q2 2026 earnings: E-commerce lifts revenue and gross margin
SenesTech’s Q2 2026 revenue rose 23% year over year to $770,000 as e-commerce revenue climbed 206% to $511,000. Gross margin reached 73.6%, up from 65.5%, reflecting a more favorable channel mix, supply costs, product mix and pricing. However, GAAP net loss widened to $1.83 million from $1.62 million as SG&A expenses increased, while loss per share narrowed to $0.35 because the weighted-average share count was substantially higher. Direct B2B revenue fell to $259,000, and quarter-end cash was $5.08 million.
TradingKey
Wed, Aug 5
K&S Fiscal Q3 2026 Earnings: Revenue More Than Doubles as Margins Recover
Kulicke & Soffa’s fiscal Q3 2026 revenue rose about 123% year over year to $330.4 million, while diluted EPS improved to $1.07 from a $0.06 loss. GAAP operating margin reached 20.7% versus negative 4.1%, supported by higher sales as management cited improving demand across all end markets. Operating cash flow was $45.2 million. For fiscal Q4, K&S guided revenue to approximately $375 million, plus or minus $20 million, and GAAP diluted EPS to about $1.29, plus or minus 10%. The reported quarter ended July 4, 2026.
TradingKey
Wed, Aug 5
Zillow Q2 2026 Earnings: Revenue Rises 18% as Margins Narrow
Zillow Group’s Q2 2026 revenue increased 18% year over year to $772 million, led by 75% Mortgage growth and 31% Rentals growth. The company posted a $4 million GAAP net loss, or $0.02 per diluted share, while adjusted EBITDA rose to $176 million at a 23% margin. Gross margin narrowed to 73%, operating cash flow fell to $11 million, and traffic declined 2%, showing that product and transaction growth outpaced housing-market activity but did not fully translate into GAAP profit or cash generation.TradingKey
Wed, Aug 5
Verra Mobility Q2 2026 Earnings: Revenue Rises 12% as Impairments Drive a GAAP Loss
Verra Mobility’s Q2 2026 revenue rose 12% to $263.6 million, while diluted EPS swung to a $0.32 loss from $0.24 of profit a year earlier. Adjusted EPS increased to $0.38 and adjusted EBITDA reached $110.7 million, although its margin narrowed to 42%. The GAAP loss reflected $104.4 million of goodwill and intangible-asset impairments in Parking Solutions. Operating cash flow fell to $56.4 million amid heavier working-capital use. Government Solutions led segment growth, and Verra Mobility revised full-year 2026 guidance to revenue of $945 million to $965 million.
TradingKey
Wed, Aug 5
UTI Fiscal Q3 2026 Earnings: Enrollment Growth Comes With Lower Profit
Universal Technical Institute’s fiscal Q3 2026 revenue rose 7.2% to $218.9 million, supported by a 10.9% increase in new student starts. Diluted EPS fell to $0.04 from $0.19, while adjusted EBITDA declined 27.8% to $18.2 million as strategic growth investments weighed on profitability. UTI lowered its fiscal 2026 revenue, earnings, adjusted EBITDA, and adjusted free cash flow guidance, citing fourth-quarter enrollment timing and mix. Nine-month adjusted free cash flow was negative $65.6 million amid elevated campus and program spending.
TradingKey
Wed, Aug 5
Honeywell Aerospace Q2 2026 earnings: Sales rise 5% as profit declines
Honeywell Aerospace’s Q2 2026 revenue rose 5% year over year to $4.52 billion, while GAAP diluted EPS fell 71% to $0.78 and adjusted EBIT declined 7% to $995 million. Commercial Aftermarket led end-market growth, but supply constraints, unfavorable mix, higher costs, and roughly $100 million of separation-related and inventory obsolescence charges pressured profitability. The company lowered full-year organic growth guidance to 4%-5% and pro forma standalone adjusted EBIT guidance to $4.35-$4.45 billion, while maintaining second-half free cash flow guidance of $1.0-$1.5 billion.TradingKey
Wed, Aug 5
Featured Tools
Top News
Oracle Stock Forecast: $630 Billion AI Order Backlog Awaits Revaluation, Can the Stock Continue to Recover?
Micron vs. SK Hynix: As HBM Demand Continues to Surge, Which Memory Stock Deserves More Attention?
New CEO Ternus Launches iPhone 18 Pro on September 9 — Can Apple Reverse Q3 China Miss Before Jackson Hole?
Micron Stock Forecast: Can AI Memory Demand Push MU Above $1,000?
Western Digital Shares Plunge 50%: Is It the Best Time to Buy?
